Two simple, rapid, selective and sensitive bioanalytical methods were developed and validated by HPLC-DAD, one for the determination and quantification of phenytoin, and another for inhibitors of P-glycoprotein (tariquidar and elacridar) using 0.2ml of plasma. The analytes were separated using Chromolith® Performance RP-18 100 - 4.6 mm column, with a mobile phase composed of ACN: 10mM acetate buffer pH = 5.2 (27.5: 72.5) for phenytoin and its EI, forthe determination of tariquidar , elacridar and its EI ACN: MeOH: 10mM acetate buffer pH = 5.2 (30:50:20) was used, in both methods a flow of 1mL / min, temperature of 25 ± 1 ° C, a complement of slingshot of 210nm The methods proved to be linear and sensitive, the phenytoin method in the range of 100 to 50,000 ng / mL (LC = 36.98 ng / mL, LD = 98.79 ng / mL) and inhibitors of 100 to 20,000 ng / mL (LC = 36.98 ng / mL, LD = 98.79 ng / mL),...

A rapid, sensitive, precise and accurate High Performance Liquid Chromatography method was developed and validated for the determination of N-3-methoxybenzyl-linoleamide levels in Sprague Dawley rat brain. During sample preparation, acetonitrile was used as extraction solvent and N-benzyl-palmitamide as internal standard. The analyte was separated on a Chromolith® Performance column with isocratic elution of acetonitrile-ultrapure water (80:20, v/v) at 1.0 mL/min and 40°C. Detection was performed using a diode array detector at a wavelength of 205 nm. The selectivity of the method was confirmed by the absence of interferences from endogenous compounds. The developed method was used to construct linear calibration curves over the concentration range of 250 and 10 000 ng/mL (R2 ≥ 0.9900). Using 500 μg of brain homogenate, the validated lower limit of quantification was 250.0 ng/mL. In...

The novel coronavirus disease 2019 or COVID-19, had been reported for the first time in December 2019, in Wuhan China. To date, around 6 777 435 cases of COVID-19 were confirmed and 395 597 deaths worldwide. The COVID-19 outbreak is the largest in the past decades and is caused by a newly discovered coronavirus (SARS-CoV-2). On March 11th, 2020, the world Health Organization (WHO) has declared the COVID-19 a “Pandemic” with high rate of morbidity and mortality. This review synthesizes the scientific evidence and reports in the literature. The content of this manuscript presents the opinions of specialists and we present our interpretation and recommendations to the Peruvian government.